One of the best-known decoy receptors used in the clinic is etanercept, a dimerized form of soluble TNF-RII conjugated to human IgG1, that can bind with high affinity to TNFα and effectively treat rheumatoid arthritis [47]. Here, TNFRSF1B is linked to rheumatoid arthritis.